EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
ADANIENT-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
AEGISLOG-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
EVOQ-MTNSE
EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 5% | -11% | 190% |
| - | 212% | -57% | -81% |
| - | - | -50% | -65% |
| 37% | 41% | 3% | 0% |
Peer Comparison
Symbol
ADANIENT-A
CPPLUS-A
PREMIERENE-A
AEGISLOG-A
REDINGTON-A
HONASA-A
LLOYDSENT-A
CELLO-A
JSLL-A
SREEL-T
EVOQ-MT
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 2,590 | ₹353335 Cr | 61.58 | 11.02 | 97.19 | ₹9339 Cr |
| 3,890 | ₹47150 Cr | 98.79 | 12.07 | 43.68 | ₹368 Cr |
| 888.9 | ₹40334 Cr | 24.22 | 10.2 | 45.28 | ₹1510 Cr |
| 1,180.25 | ₹38645 Cr | 29.01 | 7.42 | 44.04 | ₹898 Cr |
| 335.35 | ₹25810 Cr | 15.17 | 6.22 | 24.36 | ₹1490 Cr |
| 456 | ₹14727 Cr | 59.17 | 2.77 | 8.99 | ₹200 Cr |
| 60.57 | ₹9182 Cr | 81.77 | 0.38 | 0.91 | ₹283 Cr |
| 341.7 | ₹7800 Cr | 24.93 | 3.32 | 17.46 | ₹332 Cr |
| 343 | ₹4225 Cr | 17.87 | 5.31 | 23.32 | ₹222 Cr |
| 264.2 | ₹607 Cr | 18.5 | 3.02 | 14.74 | ₹29 Cr |
| 1.62 | ₹4 Cr | — | — | -0.08 | -₹24 L |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Unsecured Loans
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — |
| ₹25 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹1 L | ₹1 L | ₹1 L |
| ₹20 Cr | ₹12 Cr | ₹11 Cr | ₹10 Cr | ₹73 L | ₹1 L | ₹1 L |
| ₹20 Cr | ₹12 Cr | ₹11 Cr | ₹10 Cr | ₹73 L | ₹1 L | ₹1 L |
| ₹45 Cr | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹74 L | ₹2 L | ₹2 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹12,400 | ₹60,000 | ₹12,000 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹12,400 | ₹60,000 | ₹12,000 |
| — | — | — | — | — | — | — |
| ₹3 Cr | ₹3 Cr | -₹54 L | ₹1 Cr | ₹7 Cr | ₹6 Cr | ₹2 Cr |
| ₹1 Cr | ₹3 Cr | ₹21 L | ₹43 L | ₹20 L | ₹0 | ₹0 |
| ₹0 | ₹4 Cr | ₹10 Cr | ₹8 Cr | ₹0 | ₹0 | ₹0 |
| ₹73 L | ₹81 L | ₹87 L | ₹37 L | ₹32 L | ₹2,000 | ₹55,000 |
| ₹5 Cr | ₹12 Cr | ₹10 Cr | ₹10 Cr | ₹7 Cr | ₹6 Cr | ₹2 Cr |
| ₹50 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹8 Cr | ₹6 Cr | ₹2 Cr |
| ₹7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹4 Cr | ₹10 Cr | ₹8 Cr | ₹12,400 | ₹60,000 | ₹12,000 |
| — | — | — | — | — | — | — |
| ₹22 L | ₹1 L | ₹1 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹38,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹22 L | ₹1 L | ₹93,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹22 L | ₹1 L | ₹93,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| — | — | — | — | — | — | — |
| ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹78 L | ₹15 L | ₹6 L | ₹3 L |
| ₹9 Cr | ₹2 Cr | ₹17 Cr | ₹25 Cr | ₹7 Cr | ₹5 Cr | ₹1 Cr |
| ₹21 L | ₹12 L | ₹15 L | ₹3 Cr | ₹3 L | ₹22,000 | ₹2 L |
| ₹56 L | ₹20 L | ₹8 Cr | ₹22 L | ₹16 L | ₹15,000 | ₹10,000 |
| ₹38 Cr | ₹32 Cr | ₹8 Cr | ₹4 Cr | ₹87 L | ₹87 L | ₹87 L |
| ₹50 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹8 Cr | ₹6 Cr | ₹2 Cr |
| ₹44 Cr | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹74 L | ₹3 L | ₹2 L |
| ₹50 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹8 Cr | ₹6 Cr | ₹2 Cr |
| ₹18 | ₹19 | ₹18 | ₹17 | ₹743 | ₹23 | ₹22 |
| ₹18 | ₹19 | ₹18 | ₹17 | ₹10 | ₹0 | ₹0 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
| ₹13 L | ₹61 L | ₹2 Cr | ₹1 Cr | ₹72 L | ₹5,000 | ₹2 L |
| ₹5 L | ₹73,000 | ₹52,000 | ₹46,000 | ₹1,826 | ₹0 | ₹0 |
| -₹15 Cr | ₹5 Cr | -₹6 Cr | -₹28 Cr | -₹68 L | -₹2 L | -₹48,000 |
| -₹15 Cr | ₹5 Cr | -₹4 Cr | -₹26 Cr | ₹3 L | -₹2 L | ₹1 L |
| -₹15 Cr | ₹5 Cr | -₹4 Cr | -₹26 Cr | ₹3 L | -₹2 L | ₹63,000 |
| -₹26 L | -₹1 L | -₹1 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹15 Cr | -₹5 Cr | ₹1 Cr | ₹29 Cr | ₹0 | ₹48,000 | ₹12,000 |
| ₹9 L | -₹3 L | -₹3 Cr | ₹3 Cr | ₹3 L | -₹2 L | ₹75,000 |
| ₹12 L | ₹15 L | ₹3 Cr | ₹3 L | ₹22,183 | ₹2 L | ₹1 L |
| ₹21 L | ₹12 L | ₹15 L | ₹3 Cr | ₹3 L | ₹22,000 | ₹2 L |
Fundamental Ratios
Consolidated
Standalone
No results found
EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 4 out of 9 oscillators
RSI
46.49Neutral
STOCH %K
5.41Buy
MACD Level(12,26)
0.02Buy
Ultimate Oscillator
30.98Sell
Aroon Oscillator
34.00Sell
BOP
-1.00Sell
CCI
-10.12Neutral
Williams %R
-94.59Buy
Momentum
-0.02Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 8 out of 9 moving averages
EMA 9
1.68Sell
SMA 9
1.72Sell
EMA 21
1.67Sell
SMA 21
1.68Sell
EMA 50
1.72Sell
SMA 50
1.62Neutral
EMA 200
2.44Sell
SMA 200
2.54Sell
WMA 20
1.71Sell
Pivot
Pivot
Classic
Resistance 5
1.96
Resistance 4
1.89
Resistance 3
1.82
Resistance 2
1.75
Resistance 1
1.72
Pivot
1.68
Support 1
1.65
Support 2
1.61
Support 3
1.54
Support 4
1.47
Support 5
1.40
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|
| 0.02% | 11.21% | 11.21% | 11.21% | 11.21% | 20.53% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 99.98% | 88.79% | 88.79% | 88.79% | 88.79% | 79.47% |
Bulk & block deals
Name
Surya Prakash Jethlia
Janaki Boopalan Rajeswari
Niraj Rajnikant Shah
Niraj Rajnikant Shah
Niraj Rajnikant Shah
Panchal
Jiten Kumar Biswas
Nilesh M Suhagiya
Jiten Kumar Biswas
Nilesh M Suhagiya
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 15 Jun 2026 | Sell | 4.33 L | ₹2.64 | 1.64 L | Bulk | 0.658635 | BSE |
| 11 Dec 2025 | Sell | 3.35 L | ₹2.62 | 1.28 L | Bulk | 0.514056 | BSE |
| 08 Dec 2025 | Sell | 4.91 L | ₹2.79 | 1.76 L | Bulk | 0.706827 | BSE |
| 28 Nov 2025 | Sell | 4.39 L | ₹3.05 | 1.44 L | Bulk | 0.578313 | BSE |
| 26 Nov 2025 | Sell | 4.48 L | ₹3.11 | 1.44 L | Bulk | 0.578313 | BSE |
| 25 Nov 2025 | Sell | 5.94 L | ₹3.23 | 1.84 L | Bulk | 0.738956 | BSE |
| 20 Nov 2025 | Sell | 5.24 L | ₹3.74 | 1.40 L | Bulk | 0.562249 | BSE |
| 17 Nov 2025 | Purchase | 5.99 L | ₹3.94 | 1.52 L | Bulk | 0.610442 | BSE |
| 12 Nov 2025 | Sell | 5.33 L | ₹3.92 | 1.36 L | Bulk | 0.546185 | BSE |
| 12 Nov 2025 | Purchase | 11.60 L | ₹3.92 | 2.96 L | Bulk | 1.188755 | BSE |
Insider trading & SAST
Client name
Bhumishth Narendrabhai Patel
Payal Patel
Bhumishth Narendrabhai Patel
Bhumishth Narendrabhai Patel
Bhumishth Narendrabhai Patel
Payal Bhumishth Patel
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Oct 2025 | Promoter | Disposal | 2.15 | 0.02 | 0 | — | 5.36 L | 21 Oct 2025 | Market | 3,574 | SAST | 29(2) | — |
| 31 Oct 2025 | Promoter | Disposal | 5.78 | 0.24 | 0 | — | 14.40 L | 17 Oct 2025 | Market | 60,071 | SAST | 29(2) | — |
| 31 Oct 2025 | Promoter | Disposal | 3.02 | 2.17 | 0 | — | 7.52 L | 20 Oct 2025 | Market | 5,39,574 | SAST | 29(2) | — |
| 24 Oct 2025 | Promoter | Disposal | 2.15261 | 0.02 | 31.78 L | ₹5.93 | 5.36 L | 21 Oct 2025 | Market Sale | 3,574 | Insider Trading | — | Equity Shares |
| 23 Oct 2025 | Promoter | Disposal | 3.02008 | 2.17 | 44.22 L | ₹5.88 | 7.52 L | 20 Oct 2025 | Market Sale | 5,39,574 | Insider Trading | — | Equity Shares |
| 20 Oct 2025 | Promoter | Disposal | 5.783133 | 0.24 | 81.22 L | ₹5.64 | 14.40 L | 17 Oct 2025 | Market Sale | 60,071 | Insider Trading | — | Equity Shares |
EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
EVOQ Remedies Ltd. Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company has a team of focused industry experts, who
Corporate Actions
Date
Type
Details
Company details
EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
EVOQ Remedies Share Price
1.62-0.08 (-4.71%)
-67.01% past 1 Year
News
Evoq Remedies informs about disclosure
Equity
EVOQ
Evoq Remedies informs about disclosure
Equity
EVOQ
Evoq Remedies informs about disclosure
Equity
EVOQ
Evoq Remedies informs about corrigendum cum addendum to EGM notice
Equity
EVOQ
Evoq Remedies informs about disclosure
Equity
EVOQ
Evoq Remedies informs about updates
Equity
EVOQ
Evoq Remedies informs about revised annual report
Equity
EVOQ
Evoq Remedies informs about board meeting
Equity
EVOQ
Evoq Remedies touches roof on receiving export order of Rs 136 crore
Equity
EVOQ
Evoq Remedies receives export order of Rs 136 crore
Equity
EVOQ
Evoq Remedies informs about clarification
Equity
EVOQ